Show Notes
What the hell is going on in this house full of shit? And where do we go from here? We don't have answers, but we have ideas and plenty of questions to unfold. Power Trip 5 was a montage of stories that illustrate a bigger picture. This episode of Power Tripping offers a complementary platter of ideas. From the structural features of the psychedelic therapy marketplace, to the cognitive biases that encourage conformity and groupthink, we explore how the status quo of psychedelic therapy encourages bad behavior and complicity. What if shit's not a bug, but a feature?
Support:
☼Patreon: http://patreon.com/psymposia ☼Donate: https://www.psymposia.com/donate/
For full episodes, transcripts, supporting documents, and more, visit: https://psymposia.com/powertrip
Follow:
☼Twitter: https://twitter.com/psymposia ☼Instagram: https://www.instagram.com/psymposia/ ☼Facebook: https://www.facebook.com/psymposia ☼Twitch: https://www.twitch.tv/psymposia ☼Website: https://www.psymposia.com ☼Podcast: https://www.psymposia.com/plusthree ☼Newsletter: https://www.psymposia.com/subscribe/
Thank you to our Patreon podcast supporters:
Dave Hodges, James Hubbard, John Hanna, Dave Ayers, Tehseen Noorani, Myster Psoul, Samy Tammam, Amanda Alexander, Maryann Kehoe, Daniel McQueen, Annick McIntosh, Aaron Williams, Julia A, Christian Dawley, Dustin T, Leon Boroditsky, John Bannon, Atticus Kelbley, Daniel, Jason Gross, Clifford Hudson, Miller Hooks, Scott Martin, Sandra Dreisbach, zeph Tam, Rochella Martin, Gurpreet Saini, Jason Seidel, Will Petersen, Jeff Davis
More from The Psymposia Podcast
Normie, Mike, and Neşe discuss the upcoming MAHA Summit and its psychedelic pharmaceutical sponsors.
The crew discusses the FDA's September 14 psychedelic hearing, including Neşe's experience being in attendance, the financial conflicts of interest at the event, and the pseudoscientific beliefs of practitioners who gave testimony. Footnotes: Submit written comment to the FDA by October 5, 2026 https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for
Psymposia dives into the recent Rolling Stone article — "Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'?" — and explores how the dynamics at play in that article are pervasive within the psychedelic advocacy scene. Footnotes: Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'? (Rolling Stone): https://www.rollingstone.com/tv-movies/tv-movie-features/reggie-watts-ketamine-drug-advocate-1235607828/ Ending The Silence Around Psychedelic Therapy Abuse (Mad In America): https://www.madinamerica.com/2021/09/ending-silence-psychedelic-therapy-abuse/ Cover Story: Power Trip (Psymposia): https://www.psymposia.com/powertrip-2/ The Psychedelic Syndicate (Psymposia): https://www.psymposia.com/psychedelic-syndicate-executive-summary-silicon-valley-maps-lykos-mdma-fda-billionaires/index.html
Psymposia interviews YouTube documentarian @Alex-Novell about his experience with Andrew Callaghan and Channel 5, drug legalization, and creating documentary films. Thumbnail terminator image provided by Alex Novell.
Psymposia discusses takeaways from their "Psychedelic Conversion Therapy" series and reflects on the ten year anniversary of their "Coming Out of the Psychedelic Closet" series.